ROJKJAER LISA (EVP, Chief Medical Officer) received a stock award from RIGEL PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000905148-26-000953
Officer· EVP, Chief Medical Officer
Since Feb 2026
+18.89K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
18.89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18.89K
Price / share
—
Trade value
—
% of position
118.4%
2/17/2026
15.96K→34.85K
Total
Net shares
+18.89K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +18.89K | — | — | 118.4% | 15.96K | 34.85K |
| Total | +18.89K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported